Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-19 Sale | 2024-01-22 6:59 pm | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 18,403 | $23.67 | $435,645 | 446,597 (Direct) | View |
| 2023-12-18 Sale | 2023-12-18 8:04 pm | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 11,332 | $21.48 | $243,441 | 15,000 (Direct) | View |
| 2023-11-17 Sale | 2023-11-17 5:58 pm | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 11,342 | $18.28 | $207,293 | 26,332 (Direct) | View |
| 2023-10-18 Sale | 2023-10-18 6:22 pm | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 21,743 | $14.07 | $305,941 | 37,674 (Direct) | View |
| 2023-09-18 Sale | 2023-09-19 5:27 pm | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 21,746 | $16.22 | $352,733 | 59,417 (Direct) | View |
| 2023-08-18 Sale | 2023-08-18 7:03 pm | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 21,746 | $11.47 | $249,359 | 81,163 (Direct) | View |
| 2023-07-18 Sale | 2023-07-19 6:05 pm | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 21,749 | $11.43 | $248,519 | 102,909 (Direct) | View |
| 2023-06-20 Sale | 2023-06-21 6:46 pm | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 21,749 | $8.1559 | $177,383 | 124,658 (Direct) | View |
| 2023-05-18 Sale | 2023-05-19 6:00 pm | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 21,749 | $9.0757 | $197,387 | 146,407 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-22 Disposition | 2024-03-22 5:06 pm | N/A 2025-01-06 | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 1,735,350 | $0 | 0 (Direct) | View |
| 2024-01-24 Option Award | 2024-01-26 6:29 pm | N/A 2034-01-23 | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 150,563 | $0 | 165,563 (Direct) | View |
| 2024-01-19 Exercise | 2024-01-22 6:59 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 2,250 | $1.06 | 446,597 (Direct) | View |
| 2024-01-19 Exercise | 2024-01-22 6:59 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 3,125 | $11.69 | 446,597 (Direct) | View |
| 2024-01-19 Exercise | 2024-01-22 6:59 pm | N/A 2026-01-25 | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 18,403 | $0 | 446,597 (Direct) | View |
| 2024-01-19 Exercise | 2024-01-22 6:59 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 2,778 | $1.72 | 446,597 (Direct) | View |
| 2024-01-19 Exercise | 2024-01-22 6:59 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 1,916 | $1.82 | 446,597 (Direct) | View |
| 2024-01-19 Exercise | 2024-01-22 6:59 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 8,334 | $10 | 446,597 (Direct) | View |
| 2023-12-18 Exercise | 2023-12-18 8:04 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 11,332 | $5 | 15,000 (Direct) | View |
| 2023-12-18 Exercise | 2023-12-18 8:04 pm | N/A 2023-12-22 | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 11,332 | $0 | 15,000 (Direct) | View |
| 2023-11-17 Exercise | 2023-11-17 5:58 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 11,342 | $5 | 26,332 (Direct) | View |
| 2023-11-17 Exercise | 2023-11-17 5:58 pm | N/A 2023-12-22 | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 11,342 | $0 | 26,332 (Direct) | View |
| 2023-10-18 Exercise | 2023-10-18 6:22 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 21,743 | $5 | 37,674 (Direct) | View |
| 2023-10-18 Exercise | 2023-10-18 6:22 pm | N/A 2023-10-30 | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 21,743 | $0 | 37,674 (Direct) | View |
| 2023-09-18 Exercise | 2023-09-19 5:27 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 21,746 | $5 | 59,417 (Direct) | View |
| 2023-09-18 Exercise | 2023-09-19 5:27 pm | N/A 2023-10-30 | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 21,746 | $0 | 59,417 (Direct) | View |
| 2023-08-18 Exercise | 2023-08-18 7:03 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 21,746 | $5 | 81,163 (Direct) | View |
| 2023-08-18 Exercise | 2023-08-18 7:03 pm | N/A 2023-10-30 | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 21,746 | $0 | 81,163 (Direct) | View |
| 2023-07-18 Exercise | 2023-07-19 6:05 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 21,749 | $5 | 102,909 (Direct) | View |
| 2023-07-18 Exercise | 2023-07-19 6:05 pm | N/A 2023-10-30 | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 21,749 | $0 | 102,909 (Direct) | View |
| 2023-06-20 Exercise | 2023-06-21 6:46 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 21,749 | $5 | 124,658 (Direct) | View |
| 2023-06-20 Exercise | 2023-06-21 6:46 pm | N/A 2023-10-30 | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 21,749 | $0 | 124,658 (Direct) | View |
| 2023-05-18 Exercise | 2023-05-19 6:00 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 21,749 | $5 | 146,407 (Direct) | View |
| 2023-05-18 Exercise | 2023-05-19 6:00 pm | N/A 2023-10-30 | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 21,749 | $0 | 146,407 (Direct) | View |
| 2023-01-25 Option Award | 2023-01-27 4:27 pm | N/A 2033-01-24 | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 300,000 | $0 | 300,000 (Direct) | View |
| 2022-01-25 Option Award | 2022-01-27 4:55 pm | N/A 2032-01-24 | CymaBay Therapeutics Inc. | CBAY | McWherter Charles Chief Scientific Officer | 225,000 | $0 | 225,000 (Direct) | View |
| 2021-01-26 Option Award | 2021-01-28 2:57 pm | N/A 2031-01-25 | CymaBay Therapeutics Inc. | CBAY | McWherter Charles Chief Scientific Officer | 112,000 | $0 | 112,000 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-19 5:14 pm | N/A 2030-05-14 | CymaBay Therapeutics Inc. | CBAY | McWherter Charles SVP & Chief Scientific Officer | 328,299 | $0 | 328,299 (Direct) | View |